SEAN CONROY: Open Payments
NPI 1194180083 · JENKINTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,218 in 161 payments from 19 companies in 2025. Trend: 2023 $2,780 · 2024 $3,934 · 2025 $3,218
Food & beverage: $3,218
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 56 | $989 |
| ABBVIE INC. | 27 | $464 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $321 |
| GENZYME CORPORATION | 8 | $259 |
| Novartis Pharmaceuticals Corporation | 9 | $213 |
| E.R. Squibb & Sons, L.L.C. | 8 | $148 |
| Lilly USA, LLC | 8 | $136 |
| UCB, Inc. | 5 | $109 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| Galderma Laboratories, L.P. | 5 | $86 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, ILUMYA, COSENTYX, RINVOQ, Sotyktu, TALTZ.
Industry payments across PA — which companies pay providers there.
